Table 6.
Relative mRNA expression in PBMCs.
| Women | Men | ||||||
|---|---|---|---|---|---|---|---|
| (n = 66) | (n = 61) | ||||||
| mRNA levels | Inactive | Intermediate | Active | Inactive | Intermediate | Active | |
| (%) | (n = 20) | (n = 26) | (n = 20) | (n = 20) | (n = 15) | (n = 26) | ANOVA |
| COXIV | 1 ± 0.4 | 1.39 ± 0.5 | 5.25 ± 1.9 * | 1.23 ± 0.4 | 1.53 ± 0.8 | 4.37 ± 1.9 * | E |
| PGC1α | 1 ± 0.9 | 1.11 ± 0.7 | 1.91 ± 1.0 | 1.08 ± 0.9 | 1.12 ± 0.4 | 1.19 ± 0.6 | |
| MitND5 | 1 ± 0.4 | 0.96 ± 0.5 | 0.72 ± 0.3 | 1.32 ± 0.5 | 0.57 ± 0.01 | 1.05 ± 0.4 | |
| Mtf1 | 1 ± 0.3 | 0.80 ± 0.2 | 1.55 ± 0.8 | 0.79 ± 0.3 | 1.48 ± 0.7 | 1.38 ± 0.5 | |
| Mtf2 | 1 ± 0.5 | 1.02 ± 0.7 | 1.91 ± 0.8 | 0.83 ± 0.3 | 1.13 ± 0.7 | 1.49 ± 0.6 | |
Statistics: Two-way ANOVA. E indicates significant effects of Exercise. G indicates significant effects of Gender. Results are presented as Mean ± SEM, p < 0.05. * indicates significant differences between Active/Intermediate and Inactive groups.